Ancora Advisors’s Acura Pharmaceuticals ACUR Stock Holding History
Bought
Maintained
Sold
Ancora Advisors's ACUR Position: Q1 2026 in Review
Ancora Advisors held its Acura Pharmaceuticals (ACUR) position steady in Q1 2026 at 500 shares worth $5. The position accounts for ﹤0.01% of the portfolio, ranked #2381.
Ancora Advisors first reported a position in ACUR in Q3 2025 and has held it in 3 quarters since. 1 fund tracked by Wall St. Rank holds ACUR as of Q1 2026.
- Ancora Advisors held 500 shares of Acura Pharmaceuticals worth $5 as of Q1 2026.
- Ancora Advisors left its Acura Pharmaceuticals share count unchanged in Q1 2026.
- Acura Pharmaceuticals made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #2381 holding.
- Ancora Advisors first reported a position in Acura Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
- 1 fund tracked by Wall St. Rank held Acura Pharmaceuticals as of Q1 2026.
Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.